Skip to content

Erasca, Inc. ERAS Total Operating Expenses

Total Operating Expenses at other companies

Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$445.22M+84.9%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$48.77M+1.8%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$195.21M+192%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$61.26M+52.1%
Arrowhead Research logo
Arrowhead ResearchARWR
$215M+33.1%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$118.52M+22.8%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$4.25B+1,196%
Enterprise value$4.25B+1,265%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Erasca, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Erasca, Inc.'s total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Erasca, Inc.'s total operating expenses?
Erasca, Inc. (ERAS) reported total operating expenses of $187.91M in Q1 2026.
How has Erasca, Inc.'s total operating expenses changed year-over-year?
Erasca, Inc.'s total operating expenses increased by 427.4% year-over-year, from $35.63M to $187.91M.
What is the long-term trend for Erasca, Inc.'s total operating expenses?
Over 4 years (2021 to 2025), Erasca, Inc.'s total operating expenses has grown at a 3.1% compound annual growth rate (CAGR), from $124.88M to $140.91M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.